Trials / Completed
CompletedNCT02235103
The Predictive Value of the Sperm Chromatin Dispersion Test, Halosperm®, Before and After Sperm Preparation for Clinical Pregnancy in Cases of Unexplained Infertility Treated With Intra-uterine Insemination (First Cycle) and Ovulation Induction With Clomiphene Citrate.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 21 (actual)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Recent research has revealed that subtle abnormalities can be found in sperm samples that seem to be normal with conventional analysis techniques. The DNA in the sperm heads is sometimes fragmented and this may be the reason why couples with a diagnosis of unexplained infertility do not achieve pregnancy. We are planning a study to examine the incidence of DNA fragmentation in the sperm of couples with previously unexplained infertility. In a first treatment cycle with intra-uterine insemination the percentage of DNA fragmentation in sperm will be measured. Afterwards the results of the patients who are pregnant will be compared with those of the not pregnant ones. We expect to find differences between both groups. 100 patients will be included in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sperm Chromatin Dispersion Test |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2014-09-09
- Last updated
- 2016-03-14
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02235103. Inclusion in this directory is not an endorsement.